Safety and Midterm Outcome of Focal Pulsed Field Ablation for Outflow Tract Premature Ventricular Contractions
JACC: Clinical Electrophysiology · 2026
DOI: 10.1016/j.jacep.2026.03.032 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2026. Verfasst von Ahmad Keelani und 17 weiteren Autor:innen. Beteiligte Einrichtung: Arrhythmia Section, Division of Cardiology, Zentralklinik, Bad Berka, Germany. Hauptthemen laut MEDLINE: Catheter Ablation, Ventricular Premature Complexes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Pulsed field ablation (PFA) may overcome key limitations of radiofrequency ablation (RFA) when treating premature ventricular contractions (PVCs) in anatomically complex regions (eg, left ventricular summit or intramural outflow tract [OT]). However, the safety and efficacy of PFA in OT PVCs remain to be determined. OBJECTIVES: This study sought to assess the feasibility, safety, and midterm clinical outcomes of focal PFA for outflow tract PVCs. METHODS: In this prospective multicenter study, 80 patients with symptomatic OT PVCs underwent focal monopolar PFA using the CENTAURI generator at 4 European centers. Acute procedural outcome, complications, and mid-term efficacy were assessed. Follow-up at 3 and 6 months included 24-hour Holter electrocardiogram and clinical evaluation. Success was defined as >80% reduction in daily PVC burden off antiarrhythmic drugs. RESULTS: PVCs originated from the right ventricular OT (RVOT) in 61% of cases, with the remainder from the left ventricular OT (LVOT) and left ventricular summit. Acute procedural success was achieved in all. At a median follow-up of 8 months, clinical success was achieved in 88%, and PVC burden was significantly reduced from 21.4% (Q1-Q3: 11.9%-30.0%) before the procedure to 0.0% (Q1-Q3: 0.0%-2%) (P < 0.001) at follow-up. Success rates of ablation at the RVOT, endocardial LVOT, and left ventricular summit were 94%, 89%, and 72%, respectively. Among patients with prior failed RFA, 14 (93%) of 15 experienced no recurrence. One major (ischemic stroke; 1%) and 7 minor (9%) complications occurred. Nitroglycerin was given in 68 (85%) of 80 procedures. During ablation in the great cardiac vein/anterior interventricular vein, coronary vasospasm occurred in 2 (17%) of 12 patients, which resolved with additional nitroglycerin administration. Right bundle branch block occurred during RVOT ablation in 2 patients (1 transient, 1 permanent). CONCLUSIONS: Focal PFA provides high acute success and acceptable mid-term efficacy for OT PVCs, with outcomes comparable to contemporary RFA for RVOT and endocardial LVOT sites. Efficacy was lower for left ventricular summit and intramural substrates. Repeat procedures after failed RFA showed particularly favorable results. Coronary vasospasm occurred when PFA was delivered within the great cardiac vein/anterior interventricular vein, suggesting that venous PFA should be considered only after endocardial and alternative mapping/ablation strategies have been exhausted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Arrhythmia Section, Division of Cardiology, Zentralklinik, Bad Berka, Germany.
- University Hospital Center Split, Split, Croatia.
- Division of Electrophysiology, Department of Cardiology, Herlev-Gentofte Hospital, Hellerup, Denmark.
- Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, the Netherlands.
- Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, the Netherlands; Department of Biomedical Sciences, Faculty of Health and Medical Science…
- Arrhythmia Section, Division of Cardiology, Zentralklinik, Bad Berka, Germany; Otto-von-Guericke University, School of Medicine, Magdeburg, Germany.
Zitieren
APA
Keelani, A., Tavkhelidze, S., Lisica, L., Ruwald, M. H., Chaldoupi, S. M., Alothman, O., Borisov, G., Frommhold, M., Abdelwahab, H., Johannesen, A., Hansen, M., Worck, R., Haugdal, M., Raffa, S., Hansen, J., Linz, D., Anic, A., & Geller, J. C. (2026). Safety and Midterm Outcome of Focal Pulsed Field Ablation for Outflow Tract Premature Ventricular Contractions. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2026.03.032
Vancouver
Keelani A, Tavkhelidze S, Lisica L, Ruwald MH, Chaldoupi SM, Alothman O, et al. Safety and Midterm Outcome of Focal Pulsed Field Ablation for Outflow Tract Premature Ventricular Contractions. JACC: Clinical Electrophysiology. 2026. doi:10.1016/j.jacep.2026.03.032
BibTeX
@article{Keelani2026,
author = {Keelani, Ahmad and Tavkhelidze, Salome and Lisica, Lucija and Ruwald, Martin H and Chaldoupi, Sevasti-Maria and Alothman, Obaida and Borisov, Georgi and Frommhold, Markus and Abdelwahab, Hytham and Johannesen, Arne and Hansen, Morten and Worck, Rene and Haugdal, Martin and Raffa, Santi and Hansen, Jim and Linz, Dominik and Anic, Ante and Geller, J Christoph},
title = {Safety and Midterm Outcome of Focal Pulsed Field Ablation for Outflow Tract Premature Ventricular Contractions},
journal = {JACC: Clinical Electrophysiology},
year = {2026},
doi = {10.1016/j.jacep.2026.03.032}
}
EUVIMED